Family history in the finnish prostate cancer screening trial

International Journal of Cancer

Volumn 136, Issue 9, 2015, Pages 2172-2177

  Saarimäki, Lasse ^a   Tammela, Teuvo L ^b   Määttänen, Liisa ^c   Taari, Kimmo ^d   Kujala, Paula M ^b   Raitanen, Jani ^a,e   Auvinen, Anssi ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

Author keywords

Early detection of cancer; Familial; Prostate cancer; Prostatic neoplasms; Risk factors

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY HISTORY; FINN (CITIZEN); FIRST DEGREE RELATIVE; FOLLOW UP; GLEASON SCORE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; SECOND DEGREE RELATIVE; SENSITIVITY AND SPECIFICITY; EARLY DIAGNOSIS; MASS SCREENING; METABOLISM; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL; RISK; RISK FACTOR;

AGED; EARLY DETECTION OF CANCER; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84923124141     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29243     Document Type: Article

References (17)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46: 765-81.
2. Andriole GL, Crawford ED, Grubb RL, III, et al. Mortality results from a randomized prostatecancer screening trial. N Engl J Med 2009;360: 1310-19.
3. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8.
4. Finne P, Fallah M, Hakama M, et al. Lead-Time in the European randomised study of screening for prostate cancer. Eur J Cancer 2010;46: 3102-8.
5. Kilpelainen TP, Auvinen A, Maattanen L, et al. Results of the three rounds of the Finnish prostate cancer screening trial-The incidence of advanced cancer is decreased by screening. Int J Cancer 2010;127: 1699-705.
6. Brooks DD, Wolf A, Smith RA, et al. Prostate cancer screening 2010: Updated recommendations from the American cancer society. J Natl Med Assoc 2010;102: 423-9.
7. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94: 981-90.
8. Kilpelainen TP, Tammela TL, Roobol M, et al. False-positive screening results in the european randomized study of screening for prostate cancer. Eur J Cancer 2011;47: 2698-705.
9. Lumen N, Fonteyne V, De Meerleert G, et al. Population screening for prostate cancer: An overview of available studies and meta-Analysis. Int J Urol 2012;19: 100-8.
10. Pashayan N, Duffy SW, Pharoah P, et al. Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: Implications of sojourn time on screening. Br J Cancer 2009;100: 1198-204.
11. Bratt O. Hereditary prostate cancer: Clinical aspects. J Urol 2002;168: 906-13.
12. Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological reappraisal of the familial aggregation of prostate cancer: A meta-Analysis. PLoS One [Electronic Resource] 2011;6: E27130.
13. Matikainen MP, Schleutker J, Morsky P, et al. Detection of subclinical cancers by prostatespecific antigen screening in asymptomatic men from high-risk prostate cancer families. Clin Cancer Res 1999;5: 1275-9.
14. Finne P, Stenman U, Maattanen L, et al. The Finnish trial of prostate cancer screening: Where are we now? BJU Int Suppl 2003;92 (Suppl 2): 22-6.
15. Hakama M, Auvinen A, Day NE, et al. Sensitivity in cancer screening. J Med Screen 2007;14: 174-7.
16. Makinen T, Tammela TL, Stenman UH, et al. Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol 2002;20: 2658-63.
17. Narod SA, Dupont A, Cusan L, et al. The impact of family history on early detection of prostate cancer. Nat Med 1995;1: 99-101.